New strategies to generate induced pluripotent stem cells

Current Opinion in Biotechnology

Volumn 20, Issue 5, 2009, Pages 516-521

  O'Malley, James ^a   Woltjen, Knut ^b,c   Kaji, Keisuke ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MOUNT SINAI HOSPITAL   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOLOGOUS CELL; DRUG SCREENING; MURINE FIBROBLASTS; NEW STRATEGY; PLURIPOTENT; PLURIPOTENT STEM CELLS; RETROVIRAL TRANSDUCTION; SOMATIC CELLS; STEM CELL RESEARCH; TOXICOLOGY TESTS;

CELL CULTURE; DRUG THERAPY; TISSUE; TRANSCRIPTION FACTORS;

CELLS;

PLASMID DNA; VIRUS VECTOR;

BIOTECHNOLOGICAL PROCEDURES; BIOTECHNOLOGICAL PRODUCTION; CELL DIFFERENTIATION; DNA INTEGRATION; DNA MODIFICATION; GENE DELIVERY SYSTEM; GENETIC RECOMBINATION; GENETIC TRANSFECTION; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL DIFFERENTIATION; CELL SEPARATION; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS;

MURINAE;

EID: 70449625611     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2009.09.005     Document Type: Review

References (47)

1. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676. A landmark work. The authors generated pluripotent cells by retroviral transfection of defined factors from fibroblasts for the first time. From 24 candidate genes, they identified 4 critical reprogramming factors, Oct4, Sox2, Klf4 and c-Myc.
2. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M.P., Wulffraat N., Leboulch P., Lim A., Osborne C.S., Pawliuk R., Morillon E., et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302 (2003) 415-419
3. Hotta A., and Ellis J. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states. J Cell Biochem 105 (2008) 940-948
4. ••], the authors demonstrated that germline competent iPSCs could be generated by using selection for a more determinate pluripotent stem cell marker.
5. Aoi T., Yae K., Nakagawa M., Ichisaka T., Okita K., Takahashi K., Chiba T., and Yamanaka S. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321 (2008) 699-702
6. Wernig M., Meissner A., Cassady J.P., and Jaenisch R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2 (2008) 10-12
7. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., Okita K., Mochiduki Y., Takizawa N., and Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26 (2008) 101-106
8. Hochedlinger K., Yamada Y., Beard C., and Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121 (2005) 465-477
9. Foster K.W., Liu Z., Nail C.D., Li X., Fitzgerald T.J., Bailey S.K., Frost A.R., Louro I.D., Townes T.M., Paterson A.J., et al. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene 24 (2005) 1491-1500
10. Soldner F., Hockemeyer D., Beard C., Gao Q., Bell G.W., Cook E.G., Hargus G., Blak A., Cooper O., Mitalipova M., et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136 (2009) 964-977
11. Donnelly M.L., Luke G., Mehrotra A., Li X., Hughes L.E., Gani D., and Ryan M.D. Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'. J Gen Virol 82 (2001) 1013-1025
12. Kaji K., Norrby K., Paca A., Mileikovsky M., Mohseni P., and Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458 (2009) 771-775
13. Chang C.W., Lai Y.S., Pawlik K.M., Liu K., Sun C.W., Li C., Schoeb T.R., and Townes T.M. Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells 27 (2009) 1042-1049
14. Carey B.W., Markoulaki S., Hanna J., Saha K., Gao Q., Mitalipova M., and Jaenisch R. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A 106 (2009) 157-162
15. Sommer C.A., Stadtfeld M., Murphy G.J., Hochedlinger K., Kotton D.N., and Mostoslavsky G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27 (2009) 543-549
16. Shao L., Feng W., Sun Y., Bai H., Liu J., Currie C., Kim J., Gama R., Wang Z., Qian Z., et al. Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res 19 (2009) 296-306
17. Elick T.A., Bauser C.A., and Fraser M.J. Excision of the piggyBac transposable element in vitro is a precise event that is enhanced by the expression of its encoded transposase. Genetica 98 (1996) 33-41
18. Fraser M.J., Ciszczon T., Elick T., and Bauser C. Precise excision of TTAA-specific lepidopteran transposons piggyBac (IFP2) and tagalong (TFP3) from the baculovirus genome in cell lines from two species of Lepidoptera. Insect Mol Biol 5 (1996) 141-151
19. Woltjen K., Michael I.P., Mohseni P., Desai R., Mileikovsky M., Hamalainen R., Cowling R., Wang W., Liu P., Gertsenstein M., et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458 (2009) 766-770. piggyBac (PB) transposition was used to introduce the reprogramming factors and generate iPSCs. The transposon was successfully removed by subsequent transient expression of PB transposase in the iPSCs without any trace in the integration site. By using a doxycycline (dox)-inducible promoter, the authors also demonstrated that MEFs derived from PB-iPSCs could be reprogrammed very efficiently through the addition of dox.
20. Wang W., Lin C., Lu D., Ning Z., Cox T., Melvin D., Wang X., Bradley A., and Liu P. Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc Natl Acad Sci U S A 105 (2008) 9290-9295
21. Yusa K., Rad R., Takeda J., and Bradley A. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 6 (2009) 363-369
22. Stadtfeld M., Nagaya M., Utikal J., Weir G., and Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 322 (2008) 945-949
23. Okita K., Nakagawa M., Hyenjong H., Ichisaka T., and Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322 (2008) 949-953
24. Brambrink T., Foreman R., Welstead G.G., Lengner C.J., Wernig M., Suh H., and Jaenisch R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2 (2008) 151-159
25. Stadtfeld M., Maherali N., Breault D.T., and Hochedlinger K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2 (2008) 230-240
26. Gonzalez F., Barragan Monasterio M., Tiscornia G., Montserrat Pulido N., Vassena R., Batlle-Morera L., Rodriguez Piza I., and Izpisua Belmonte J.C. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci U S A 106 (2009) 8918-8922
27. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872. One of the first papers, which reported human iPSC generation. The same genes used for murine cell reprogramming were successfully applied to human cell reprogramming. Human ES cell culture conditions were used instead of that of murine ES cells after viral infection.
28. Yu J., Hu K., Smuga-Otto K., Tian S., Stewart R., Slukvin I.I., and Thomson J.A. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324 (2009) 797-801
29. Yates J.L., Warren N., and Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313 (1985) 812-815
30. Nanbo A., Sugden A., and Sugden B. The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells. EMBO J 26 (2007) 4252-4262
31. Shi Y., Desponts C., Do J.T., Hahm H.S., Scholer H.R., and Ding S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3 (2008) 568-574
32. Huangfu D., Osafune K., Maehr R., Guo W., Eijkelenboom A., Chen S., Muhlestein W., and Melton D.A. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26 (2008) 1269-1275
33. Lyssiotis C.A., Foreman R.K., Staerk J., Garcia M., Mathur D., Markoulaki S., Hanna J., Lairson L.L., Charette B.D., Bouchez L.C., et al. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci U S A 106 (2009) 8912-8917
34. Zhou H., Wu S., Joo J.Y., Zhu S., Han D.W., Lin T., Trauger S., Bien G., Yao S., Zhu Y., et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4 (2009) 381-384
35. Kim D., Kim C.H., Moon J.I., Chung Y.G., Chang M.Y., Han B.S., Ko S., Yang E., Cha K.Y., Lanza R., et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4 (2009) 472-476
36. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Lerou P.H., Lensch M.W., and Daley G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451 (2008) 141-146. Another early paper reporting human iPSC generation. This group used the SV40 large T antigen and TERT in addition to OCT4, SOX2, KLF4 and c-MYC. However, neither integration of the SV40 large T antigen nor TERT was found in the human iPSCs.
37. Aasen T., Raya A., Barrero M.J., Garreta E., Consiglio A., Gonzalez F., Vassena R., Bilic J., Pekarik V., Tiscornia G., et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26 (2008) 1276-1284. The authors showed that reprogramming of human keratinocytes is ∼100-fold more efficient and 2-fold faster as compared to human fibroblasts. The keratinocyte-derived iPSCs also had fewer retroviral integrations.
38. Jaenisch R., and Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132 (2008) 567-582
39. Allegrucci C., and Young L.E. Differences between human embryonic stem cell lines. Hum Reprod Update 13 (2007) 103-120
40. Markoulaki S., Hanna J., Beard C., Carey B.W., Cheng A.W., Lengner C.J., Dausman J.A., Fu D., Gao Q., Wu S., et al. Transgenic mice with defined combinations of drug-inducible reprogramming factors. Nat Biotechnol 27 (2009) 169-171
41. Wernig M., Lengner C.J., Hanna J., Lodato M.A., Steine E., Foreman R., Staerk J., Markoulaki S., and Jaenisch R. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 26 (2008) 916-924. The authors used doxycycline-inducible lentiviral vectors to generate iPSCs, which were subsequently used to generate differentiated cells with genetically identical reprogramming factor integrations. Reprogramming of different cell types was tested through the addition of dox in this 'secondary reprogramming' system.
42. Feng B., Ng J.H., Heng J.C., and Ng H.H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 4 (2009) 301-312. A late review about small molecules used for reprogramming. Useful to catch up on their role in the rapid development of reprogramming technologies.
43. Silva J., Barrandon O., Nichols J., Kawaguchi J., Theunissen T.W., and Smith A. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 6 (2008) e253
44. Ying Q.L., Wray J., Nichols J., Batlle-Morera L., Doble B., Woodgett J., Cohen P., and Smith A. The ground state of embryonic stem cell self-renewal. Nature 453 (2008) 519-523. Mouse ESC self-renewal was enabled by the inhibition of GSK3b and ERK signalling pathways, suggesting ES cells have an innate programme for self-replication that does not require extrinsic instruction. These culture conditions have been applied to iPSC derivation [43,47].
45. Buehr M., Meek S., Blair K., Yang J., Ure J., Silva J., McLay R., Hall J., Ying Q.L., and Smith A. Capture of authentic embryonic stem cells from rat blastocysts. Cell 135 (2008) 1287-1298
46. Li P., Tong C., Mehrian-Shai R., Jia L., Wu N., Yan Y., Maxson R.E., Schulze E.N., Song H., Hsieh C.L., et al. Germline competent embryonic stem cells derived from rat blastocysts. Cell 135 (2008) 1299-1310
47. Li W., Wei W., Zhu S., Zhu J., Shi Y., Lin T., Hao E., Hayek A., Deng H., and Ding S. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4 (2009) 16-19